It has been reported that a versacross connect access solution was selected for use.A perforation, a pericardial effusion (pe) and cardiac tamponade occurred, and the procedure was cancelled.During watchman procedure, right femoral access was achieved.The transesophageal echocardiography (tee) showed a trace pe and no clotting in the appendage.Baseline measurements were performed, and heparin was given.The watchman sheath and the versacross dilator were advanced over the versacross rf wire into the superior vena cava (svc).Using tee, a safe inferior and mid transseptal crossing was successfully achieved (no issues noted).The system was then advanced into the left atrium.When the dilator was being removed from the sheath, the rf wire accidentally also got pulled back into the sheath.When the physician was attempting to advance the rf wire back through, they experienced resistance.At this point, tee was unable to visualize the device, and so fluoroscopy was used.Suddenly, the patient's blood pressure began dropping to 50/38 and a pe was noted behind the right and left ventricle.Protamine was given and a pericardiocentesis was performed, removing roughly 750ccs of blood from the body.The patient was then stabilized and a cardiac care unit (ccu) bed was ordered.The patient was successfully discharged from the facility on (b)(6) 2024.The device is not expected to be returned for analysis.In the physician's opinion, the versacross device contributed to the complications.After transseptal, the physician accidentally removed the versacross rf wire with the dilator, upon reinsertion of the rf wire, resistance was felt.The pe grew significantly throughout the procedure but returned to baseline at the end.Patient was not on warfarin or antiplatelet drugs at the time of procedure.There is no reason to believe that the versacross dilator malfunctioned during the procedure.They also confirmed that a full dose of heparin was given prior to transseptal and act was therapeutic during the procedure.
|